nodes	percent_of_prediction	percent_of_DWPC	metapath
Terazosin—ABCB1—Progesterone—uterine cancer	0.0998	0.393	CbGbCtD
Terazosin—ABCB1—Dactinomycin—uterine cancer	0.0792	0.311	CbGbCtD
Terazosin—ABCB1—Etoposide—uterine cancer	0.0447	0.176	CbGbCtD
Terazosin—ABCB1—Doxorubicin—uterine cancer	0.0305	0.12	CbGbCtD
Terazosin—KCNH6—renal system—uterine cancer	0.00769	0.112	CbGeAlD
Terazosin—KCNH6—uterus—uterine cancer	0.00685	0.0999	CbGeAlD
Terazosin—KCNH6—female reproductive system—uterine cancer	0.00616	0.0898	CbGeAlD
Terazosin—ADRA1D—epithelium—uterine cancer	0.00459	0.067	CbGeAlD
Terazosin—ADRA1B—renal system—uterine cancer	0.00435	0.0635	CbGeAlD
Terazosin—ADRA1D—female reproductive system—uterine cancer	0.00341	0.0498	CbGeAlD
Terazosin—KCNH2—myometrium—uterine cancer	0.00324	0.0473	CbGeAlD
Terazosin—ADRA1A—epithelium—uterine cancer	0.00264	0.0385	CbGeAlD
Terazosin—KCNH2—uterine cervix—uterine cancer	0.00252	0.0368	CbGeAlD
Terazosin—ADRA1A—renal system—uterine cancer	0.00245	0.0357	CbGeAlD
Terazosin—KCNH2—renal system—uterine cancer	0.00236	0.0345	CbGeAlD
Terazosin—KCNH2—endometrium—uterine cancer	0.00228	0.0333	CbGeAlD
Terazosin—KCNH2—uterus—uterine cancer	0.0021	0.0307	CbGeAlD
Terazosin—KCNH2—female reproductive system—uterine cancer	0.00189	0.0276	CbGeAlD
Terazosin—KCNH2—female gonad—uterine cancer	0.00172	0.0251	CbGeAlD
Terazosin—KCNH2—vagina—uterine cancer	0.00171	0.025	CbGeAlD
Terazosin—Pruritus—Progesterone—uterine cancer	0.00149	0.00219	CcSEcCtD
Terazosin—Oedema—Dactinomycin—uterine cancer	0.00148	0.00219	CcSEcCtD
Terazosin—Abnormal vision—Epirubicin—uterine cancer	0.00147	0.00217	CcSEcCtD
Terazosin—Thrombocytopenia—Dactinomycin—uterine cancer	0.00145	0.00214	CcSEcCtD
Terazosin—Diarrhoea—Progesterone—uterine cancer	0.00144	0.00212	CcSEcCtD
Terazosin—ABCB1—myometrium—uterine cancer	0.00142	0.0208	CbGeAlD
Terazosin—Anorexia—Dactinomycin—uterine cancer	0.00141	0.00209	CcSEcCtD
Terazosin—Eye disorder—Etoposide—uterine cancer	0.00141	0.00209	CcSEcCtD
Terazosin—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.0014	0.00207	CcSEcCtD
Terazosin—Photosensitivity—Epirubicin—uterine cancer	0.00139	0.00206	CcSEcCtD
Terazosin—Dizziness—Progesterone—uterine cancer	0.00139	0.00205	CcSEcCtD
Terazosin—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00136	0.00201	CcSEcCtD
Terazosin—Abnormal vision—Doxorubicin—uterine cancer	0.00136	0.00201	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00135	0.002	CcSEcCtD
Terazosin—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00135	0.00199	CcSEcCtD
Terazosin—Vomiting—Progesterone—uterine cancer	0.00133	0.00197	CcSEcCtD
Terazosin—Rash—Progesterone—uterine cancer	0.00132	0.00195	CcSEcCtD
Terazosin—Dermatitis—Progesterone—uterine cancer	0.00132	0.00195	CcSEcCtD
Terazosin—Headache—Progesterone—uterine cancer	0.00132	0.00194	CcSEcCtD
Terazosin—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.0013	0.00192	CcSEcCtD
Terazosin—Photosensitivity—Doxorubicin—uterine cancer	0.00129	0.00191	CcSEcCtD
Terazosin—Decreased appetite—Dactinomycin—uterine cancer	0.00129	0.0019	CcSEcCtD
Terazosin—Dysgeusia—Etoposide—uterine cancer	0.00129	0.0019	CcSEcCtD
Terazosin—Fatigue—Dactinomycin—uterine cancer	0.00128	0.00189	CcSEcCtD
Terazosin—Back pain—Etoposide—uterine cancer	0.00127	0.00188	CcSEcCtD
Terazosin—Pain—Dactinomycin—uterine cancer	0.00127	0.00187	CcSEcCtD
Terazosin—Anaphylactoid reaction—Epirubicin—uterine cancer	0.00127	0.00187	CcSEcCtD
Terazosin—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00126	0.00186	CcSEcCtD
Terazosin—Cardiac failure—Epirubicin—uterine cancer	0.00125	0.00185	CcSEcCtD
Terazosin—Cerebrovascular accident—Epirubicin—uterine cancer	0.00125	0.00185	CcSEcCtD
Terazosin—Nausea—Progesterone—uterine cancer	0.00125	0.00184	CcSEcCtD
Terazosin—Pain in extremity—Epirubicin—uterine cancer	0.00122	0.00181	CcSEcCtD
Terazosin—Osteoarthritis—Epirubicin—uterine cancer	0.00122	0.00181	CcSEcCtD
Terazosin—Feeling abnormal—Dactinomycin—uterine cancer	0.00122	0.00181	CcSEcCtD
Terazosin—Ill-defined disorder—Etoposide—uterine cancer	0.00122	0.0018	CcSEcCtD
Terazosin—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00121	0.00179	CcSEcCtD
Terazosin—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00121	0.00179	CcSEcCtD
Terazosin—Migraine—Epirubicin—uterine cancer	0.00121	0.00178	CcSEcCtD
Terazosin—Rash—Medroxyprogesterone Acetate—uterine cancer	0.0012	0.00177	CcSEcCtD
Terazosin—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.0012	0.00177	CcSEcCtD
Terazosin—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00119	0.00176	CcSEcCtD
Terazosin—Malaise—Etoposide—uterine cancer	0.00119	0.00175	CcSEcCtD
Terazosin—Face oedema—Epirubicin—uterine cancer	0.00118	0.00175	CcSEcCtD
Terazosin—Vertigo—Etoposide—uterine cancer	0.00118	0.00175	CcSEcCtD
Terazosin—Abdominal pain—Dactinomycin—uterine cancer	0.00117	0.00173	CcSEcCtD
Terazosin—Body temperature increased—Dactinomycin—uterine cancer	0.00117	0.00173	CcSEcCtD
Terazosin—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.00117	0.00173	CcSEcCtD
Terazosin—Cardiac failure—Doxorubicin—uterine cancer	0.00116	0.00171	CcSEcCtD
Terazosin—Loss of consciousness—Etoposide—uterine cancer	0.00116	0.00171	CcSEcCtD
Terazosin—Cerebrovascular accident—Doxorubicin—uterine cancer	0.00116	0.00171	CcSEcCtD
Terazosin—Cough—Etoposide—uterine cancer	0.00115	0.0017	CcSEcCtD
Terazosin—Convulsion—Etoposide—uterine cancer	0.00114	0.00168	CcSEcCtD
Terazosin—Osteoarthritis—Doxorubicin—uterine cancer	0.00113	0.00167	CcSEcCtD
Terazosin—Pain in extremity—Doxorubicin—uterine cancer	0.00113	0.00167	CcSEcCtD
Terazosin—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00113	0.00167	CcSEcCtD
Terazosin—Chest pain—Etoposide—uterine cancer	0.00112	0.00165	CcSEcCtD
Terazosin—Orthostatic hypotension—Epirubicin—uterine cancer	0.00112	0.00165	CcSEcCtD
Terazosin—ABCB1—epithelium—uterine cancer	0.00112	0.0163	CbGeAlD
Terazosin—Migraine—Doxorubicin—uterine cancer	0.00112	0.00165	CcSEcCtD
Terazosin—Hypokalaemia—Epirubicin—uterine cancer	0.00111	0.00165	CcSEcCtD
Terazosin—ABCB1—uterine cervix—uterine cancer	0.00111	0.0162	CbGeAlD
Terazosin—Discomfort—Etoposide—uterine cancer	0.00111	0.00163	CcSEcCtD
Terazosin—KCNH2—lymph node—uterine cancer	0.00111	0.0161	CbGeAlD
Terazosin—Nasopharyngitis—Epirubicin—uterine cancer	0.0011	0.00162	CcSEcCtD
Terazosin—Face oedema—Doxorubicin—uterine cancer	0.00109	0.00162	CcSEcCtD
Terazosin—Hypersensitivity—Dactinomycin—uterine cancer	0.00109	0.00161	CcSEcCtD
Terazosin—Gastritis—Epirubicin—uterine cancer	0.00108	0.0016	CcSEcCtD
Terazosin—Confusional state—Etoposide—uterine cancer	0.00108	0.0016	CcSEcCtD
Terazosin—Anaphylactic shock—Etoposide—uterine cancer	0.00107	0.00159	CcSEcCtD
Terazosin—Asthenia—Dactinomycin—uterine cancer	0.00106	0.00157	CcSEcCtD
Terazosin—Influenza—Epirubicin—uterine cancer	0.00106	0.00156	CcSEcCtD
Terazosin—Asthma—Epirubicin—uterine cancer	0.00106	0.00156	CcSEcCtD
Terazosin—ABCB1—decidua—uterine cancer	0.00106	0.0154	CbGeAlD
Terazosin—Thrombocytopenia—Etoposide—uterine cancer	0.00105	0.00155	CcSEcCtD
Terazosin—Tachycardia—Etoposide—uterine cancer	0.00105	0.00155	CcSEcCtD
Terazosin—Hyperhidrosis—Etoposide—uterine cancer	0.00104	0.00153	CcSEcCtD
Terazosin—ABCB1—renal system—uterine cancer	0.00104	0.0151	CbGeAlD
Terazosin—Orthostatic hypotension—Doxorubicin—uterine cancer	0.00103	0.00153	CcSEcCtD
Terazosin—Hypokalaemia—Doxorubicin—uterine cancer	0.00103	0.00152	CcSEcCtD
Terazosin—Angina pectoris—Epirubicin—uterine cancer	0.00103	0.00152	CcSEcCtD
Terazosin—Anorexia—Etoposide—uterine cancer	0.00102	0.00151	CcSEcCtD
Terazosin—Bronchitis—Epirubicin—uterine cancer	0.00102	0.0015	CcSEcCtD
Terazosin—Diarrhoea—Dactinomycin—uterine cancer	0.00102	0.0015	CcSEcCtD
Terazosin—Nasopharyngitis—Doxorubicin—uterine cancer	0.00101	0.0015	CcSEcCtD
Terazosin—Hypotension—Etoposide—uterine cancer	0.001	0.00148	CcSEcCtD
Terazosin—Gastritis—Doxorubicin—uterine cancer	0.001	0.00148	CcSEcCtD
Terazosin—ABCB1—endometrium—uterine cancer	0.001	0.0146	CbGeAlD
Terazosin—Dysuria—Epirubicin—uterine cancer	0.00099	0.00146	CcSEcCtD
Terazosin—Influenza—Doxorubicin—uterine cancer	0.000979	0.00145	CcSEcCtD
Terazosin—Asthma—Doxorubicin—uterine cancer	0.000979	0.00145	CcSEcCtD
Terazosin—Pollakiuria—Epirubicin—uterine cancer	0.000978	0.00144	CcSEcCtD
Terazosin—ABCB1—mammalian vulva—uterine cancer	0.000969	0.0141	CbGeAlD
Terazosin—Photosensitivity reaction—Epirubicin—uterine cancer	0.000966	0.00143	CcSEcCtD
Terazosin—Paraesthesia—Etoposide—uterine cancer	0.000964	0.00142	CcSEcCtD
Terazosin—Weight increased—Epirubicin—uterine cancer	0.000963	0.00142	CcSEcCtD
Terazosin—Dyspnoea—Etoposide—uterine cancer	0.000957	0.00141	CcSEcCtD
Terazosin—Somnolence—Etoposide—uterine cancer	0.000955	0.00141	CcSEcCtD
Terazosin—Angina pectoris—Doxorubicin—uterine cancer	0.000954	0.00141	CcSEcCtD
Terazosin—Vomiting—Dactinomycin—uterine cancer	0.000943	0.00139	CcSEcCtD
Terazosin—Bronchitis—Doxorubicin—uterine cancer	0.000942	0.00139	CcSEcCtD
Terazosin—Rash—Dactinomycin—uterine cancer	0.000935	0.00138	CcSEcCtD
Terazosin—Decreased appetite—Etoposide—uterine cancer	0.000933	0.00138	CcSEcCtD
Terazosin—Fatigue—Etoposide—uterine cancer	0.000926	0.00137	CcSEcCtD
Terazosin—ABCB1—uterus—uterine cancer	0.000923	0.0135	CbGeAlD
Terazosin—Jaundice—Epirubicin—uterine cancer	0.00092	0.00136	CcSEcCtD
Terazosin—Constipation—Etoposide—uterine cancer	0.000918	0.00136	CcSEcCtD
Terazosin—Pain—Etoposide—uterine cancer	0.000918	0.00136	CcSEcCtD
Terazosin—Conjunctivitis—Epirubicin—uterine cancer	0.000917	0.00135	CcSEcCtD
Terazosin—Urinary tract infection—Epirubicin—uterine cancer	0.000917	0.00135	CcSEcCtD
Terazosin—Dysuria—Doxorubicin—uterine cancer	0.000916	0.00135	CcSEcCtD
Terazosin—Sweating—Epirubicin—uterine cancer	0.000905	0.00134	CcSEcCtD
Terazosin—Pollakiuria—Doxorubicin—uterine cancer	0.000905	0.00134	CcSEcCtD
Terazosin—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000894	0.00132	CcSEcCtD
Terazosin—Weight increased—Doxorubicin—uterine cancer	0.000891	0.00132	CcSEcCtD
Terazosin—Epistaxis—Epirubicin—uterine cancer	0.00089	0.00131	CcSEcCtD
Terazosin—Sinusitis—Epirubicin—uterine cancer	0.000885	0.00131	CcSEcCtD
Terazosin—Feeling abnormal—Etoposide—uterine cancer	0.000885	0.00131	CcSEcCtD
Terazosin—Nausea—Dactinomycin—uterine cancer	0.000881	0.0013	CcSEcCtD
Terazosin—Gastrointestinal pain—Etoposide—uterine cancer	0.000878	0.0013	CcSEcCtD
Terazosin—Jaundice—Doxorubicin—uterine cancer	0.000851	0.00126	CcSEcCtD
Terazosin—Rhinitis—Epirubicin—uterine cancer	0.000849	0.00125	CcSEcCtD
Terazosin—Abdominal pain—Etoposide—uterine cancer	0.000849	0.00125	CcSEcCtD
Terazosin—Body temperature increased—Etoposide—uterine cancer	0.000849	0.00125	CcSEcCtD
Terazosin—Conjunctivitis—Doxorubicin—uterine cancer	0.000849	0.00125	CcSEcCtD
Terazosin—Urinary tract infection—Doxorubicin—uterine cancer	0.000849	0.00125	CcSEcCtD
Terazosin—Pharyngitis—Epirubicin—uterine cancer	0.000841	0.00124	CcSEcCtD
Terazosin—Sweating—Doxorubicin—uterine cancer	0.000837	0.00124	CcSEcCtD
Terazosin—Oedema peripheral—Epirubicin—uterine cancer	0.000835	0.00123	CcSEcCtD
Terazosin—ABCB1—female reproductive system—uterine cancer	0.00083	0.0121	CbGeAlD
Terazosin—Epistaxis—Doxorubicin—uterine cancer	0.000824	0.00122	CcSEcCtD
Terazosin—Sinusitis—Doxorubicin—uterine cancer	0.000819	0.00121	CcSEcCtD
Terazosin—Visual impairment—Epirubicin—uterine cancer	0.000816	0.00121	CcSEcCtD
Terazosin—Eye disorder—Epirubicin—uterine cancer	0.000792	0.00117	CcSEcCtD
Terazosin—Hypersensitivity—Etoposide—uterine cancer	0.000791	0.00117	CcSEcCtD
Terazosin—Tinnitus—Epirubicin—uterine cancer	0.00079	0.00117	CcSEcCtD
Terazosin—Rhinitis—Doxorubicin—uterine cancer	0.000786	0.00116	CcSEcCtD
Terazosin—Pharyngitis—Doxorubicin—uterine cancer	0.000778	0.00115	CcSEcCtD
Terazosin—Oedema peripheral—Doxorubicin—uterine cancer	0.000772	0.00114	CcSEcCtD
Terazosin—Asthenia—Etoposide—uterine cancer	0.00077	0.00114	CcSEcCtD
Terazosin—Pruritus—Etoposide—uterine cancer	0.00076	0.00112	CcSEcCtD
Terazosin—Arrhythmia—Epirubicin—uterine cancer	0.000757	0.00112	CcSEcCtD
Terazosin—Visual impairment—Doxorubicin—uterine cancer	0.000755	0.00112	CcSEcCtD
Terazosin—ABCB1—female gonad—uterine cancer	0.000755	0.011	CbGeAlD
Terazosin—ABCB1—vagina—uterine cancer	0.00075	0.011	CbGeAlD
Terazosin—Malnutrition—Epirubicin—uterine cancer	0.000738	0.00109	CcSEcCtD
Terazosin—Diarrhoea—Etoposide—uterine cancer	0.000735	0.00108	CcSEcCtD
Terazosin—Eye disorder—Doxorubicin—uterine cancer	0.000733	0.00108	CcSEcCtD
Terazosin—Tinnitus—Doxorubicin—uterine cancer	0.000731	0.00108	CcSEcCtD
Terazosin—Flatulence—Epirubicin—uterine cancer	0.000727	0.00107	CcSEcCtD
Terazosin—Tension—Epirubicin—uterine cancer	0.000724	0.00107	CcSEcCtD
Terazosin—Dysgeusia—Epirubicin—uterine cancer	0.000722	0.00107	CcSEcCtD
Terazosin—Nervousness—Epirubicin—uterine cancer	0.000716	0.00106	CcSEcCtD
Terazosin—Back pain—Epirubicin—uterine cancer	0.000713	0.00105	CcSEcCtD
Terazosin—Dizziness—Etoposide—uterine cancer	0.00071	0.00105	CcSEcCtD
Terazosin—Arrhythmia—Doxorubicin—uterine cancer	0.0007	0.00103	CcSEcCtD
Terazosin—Vision blurred—Epirubicin—uterine cancer	0.000695	0.00103	CcSEcCtD
Terazosin—Ill-defined disorder—Epirubicin—uterine cancer	0.000684	0.00101	CcSEcCtD
Terazosin—Vomiting—Etoposide—uterine cancer	0.000683	0.00101	CcSEcCtD
Terazosin—Malnutrition—Doxorubicin—uterine cancer	0.000682	0.00101	CcSEcCtD
Terazosin—Rash—Etoposide—uterine cancer	0.000677	0.001	CcSEcCtD
Terazosin—Dermatitis—Etoposide—uterine cancer	0.000676	0.000999	CcSEcCtD
Terazosin—Headache—Etoposide—uterine cancer	0.000673	0.000993	CcSEcCtD
Terazosin—Flatulence—Doxorubicin—uterine cancer	0.000672	0.000993	CcSEcCtD
Terazosin—Tension—Doxorubicin—uterine cancer	0.00067	0.000989	CcSEcCtD
Terazosin—Dysgeusia—Doxorubicin—uterine cancer	0.000668	0.000987	CcSEcCtD
Terazosin—Malaise—Epirubicin—uterine cancer	0.000665	0.000982	CcSEcCtD
Terazosin—Nervousness—Doxorubicin—uterine cancer	0.000663	0.000979	CcSEcCtD
Terazosin—Vertigo—Epirubicin—uterine cancer	0.000663	0.000978	CcSEcCtD
Terazosin—Syncope—Epirubicin—uterine cancer	0.000661	0.000977	CcSEcCtD
Terazosin—Back pain—Doxorubicin—uterine cancer	0.00066	0.000975	CcSEcCtD
Terazosin—Palpitations—Epirubicin—uterine cancer	0.000652	0.000962	CcSEcCtD
Terazosin—Loss of consciousness—Epirubicin—uterine cancer	0.000648	0.000957	CcSEcCtD
Terazosin—Cough—Epirubicin—uterine cancer	0.000644	0.00095	CcSEcCtD
Terazosin—Vision blurred—Doxorubicin—uterine cancer	0.000643	0.00095	CcSEcCtD
Terazosin—Convulsion—Epirubicin—uterine cancer	0.000639	0.000943	CcSEcCtD
Terazosin—Nausea—Etoposide—uterine cancer	0.000638	0.000942	CcSEcCtD
Terazosin—Ill-defined disorder—Doxorubicin—uterine cancer	0.000633	0.000935	CcSEcCtD
Terazosin—Chest pain—Epirubicin—uterine cancer	0.000628	0.000927	CcSEcCtD
Terazosin—Myalgia—Epirubicin—uterine cancer	0.000628	0.000927	CcSEcCtD
Terazosin—Arthralgia—Epirubicin—uterine cancer	0.000628	0.000927	CcSEcCtD
Terazosin—Anxiety—Epirubicin—uterine cancer	0.000626	0.000924	CcSEcCtD
Terazosin—Discomfort—Epirubicin—uterine cancer	0.00062	0.000916	CcSEcCtD
Terazosin—Malaise—Doxorubicin—uterine cancer	0.000615	0.000909	CcSEcCtD
Terazosin—Dry mouth—Epirubicin—uterine cancer	0.000614	0.000907	CcSEcCtD
Terazosin—Vertigo—Doxorubicin—uterine cancer	0.000613	0.000905	CcSEcCtD
Terazosin—Syncope—Doxorubicin—uterine cancer	0.000612	0.000904	CcSEcCtD
Terazosin—Confusional state—Epirubicin—uterine cancer	0.000607	0.000896	CcSEcCtD
Terazosin—Palpitations—Doxorubicin—uterine cancer	0.000603	0.00089	CcSEcCtD
Terazosin—Anaphylactic shock—Epirubicin—uterine cancer	0.000602	0.000889	CcSEcCtD
Terazosin—Oedema—Epirubicin—uterine cancer	0.000602	0.000889	CcSEcCtD
Terazosin—Loss of consciousness—Doxorubicin—uterine cancer	0.0006	0.000886	CcSEcCtD
Terazosin—Cough—Doxorubicin—uterine cancer	0.000596	0.000879	CcSEcCtD
Terazosin—Shock—Epirubicin—uterine cancer	0.000592	0.000874	CcSEcCtD
Terazosin—Convulsion—Doxorubicin—uterine cancer	0.000591	0.000873	CcSEcCtD
Terazosin—Thrombocytopenia—Epirubicin—uterine cancer	0.000589	0.00087	CcSEcCtD
Terazosin—Tachycardia—Epirubicin—uterine cancer	0.000587	0.000867	CcSEcCtD
Terazosin—Hyperhidrosis—Epirubicin—uterine cancer	0.000582	0.000859	CcSEcCtD
Terazosin—Arthralgia—Doxorubicin—uterine cancer	0.000581	0.000858	CcSEcCtD
Terazosin—Myalgia—Doxorubicin—uterine cancer	0.000581	0.000858	CcSEcCtD
Terazosin—Chest pain—Doxorubicin—uterine cancer	0.000581	0.000858	CcSEcCtD
Terazosin—Anxiety—Doxorubicin—uterine cancer	0.000579	0.000855	CcSEcCtD
Terazosin—Discomfort—Doxorubicin—uterine cancer	0.000574	0.000848	CcSEcCtD
Terazosin—Anorexia—Epirubicin—uterine cancer	0.000574	0.000847	CcSEcCtD
Terazosin—Dry mouth—Doxorubicin—uterine cancer	0.000568	0.000839	CcSEcCtD
Terazosin—Hypotension—Epirubicin—uterine cancer	0.000562	0.00083	CcSEcCtD
Terazosin—Confusional state—Doxorubicin—uterine cancer	0.000562	0.000829	CcSEcCtD
Terazosin—Oedema—Doxorubicin—uterine cancer	0.000557	0.000822	CcSEcCtD
Terazosin—Anaphylactic shock—Doxorubicin—uterine cancer	0.000557	0.000822	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000548	0.00081	CcSEcCtD
Terazosin—Shock—Doxorubicin—uterine cancer	0.000548	0.000809	CcSEcCtD
Terazosin—Thrombocytopenia—Doxorubicin—uterine cancer	0.000545	0.000805	CcSEcCtD
Terazosin—Insomnia—Epirubicin—uterine cancer	0.000544	0.000804	CcSEcCtD
Terazosin—Tachycardia—Doxorubicin—uterine cancer	0.000544	0.000803	CcSEcCtD
Terazosin—Paraesthesia—Epirubicin—uterine cancer	0.000541	0.000798	CcSEcCtD
Terazosin—Hyperhidrosis—Doxorubicin—uterine cancer	0.000538	0.000795	CcSEcCtD
Terazosin—Dyspnoea—Epirubicin—uterine cancer	0.000537	0.000792	CcSEcCtD
Terazosin—Somnolence—Epirubicin—uterine cancer	0.000535	0.00079	CcSEcCtD
Terazosin—Anorexia—Doxorubicin—uterine cancer	0.000531	0.000784	CcSEcCtD
Terazosin—Dyspepsia—Epirubicin—uterine cancer	0.00053	0.000782	CcSEcCtD
Terazosin—Decreased appetite—Epirubicin—uterine cancer	0.000523	0.000773	CcSEcCtD
Terazosin—Hypotension—Doxorubicin—uterine cancer	0.00052	0.000768	CcSEcCtD
Terazosin—Fatigue—Epirubicin—uterine cancer	0.000519	0.000766	CcSEcCtD
Terazosin—Pain—Epirubicin—uterine cancer	0.000515	0.00076	CcSEcCtD
Terazosin—Constipation—Epirubicin—uterine cancer	0.000515	0.00076	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000507	0.000749	CcSEcCtD
Terazosin—Insomnia—Doxorubicin—uterine cancer	0.000504	0.000744	CcSEcCtD
Terazosin—Paraesthesia—Doxorubicin—uterine cancer	0.0005	0.000738	CcSEcCtD
Terazosin—Dyspnoea—Doxorubicin—uterine cancer	0.000497	0.000733	CcSEcCtD
Terazosin—Feeling abnormal—Epirubicin—uterine cancer	0.000496	0.000732	CcSEcCtD
Terazosin—Somnolence—Doxorubicin—uterine cancer	0.000495	0.000731	CcSEcCtD
Terazosin—Gastrointestinal pain—Epirubicin—uterine cancer	0.000492	0.000727	CcSEcCtD
Terazosin—Dyspepsia—Doxorubicin—uterine cancer	0.00049	0.000724	CcSEcCtD
Terazosin—ABCB1—lymph node—uterine cancer	0.000485	0.00708	CbGeAlD
Terazosin—Decreased appetite—Doxorubicin—uterine cancer	0.000484	0.000715	CcSEcCtD
Terazosin—Fatigue—Doxorubicin—uterine cancer	0.00048	0.000709	CcSEcCtD
Terazosin—Pain—Doxorubicin—uterine cancer	0.000476	0.000703	CcSEcCtD
Terazosin—Constipation—Doxorubicin—uterine cancer	0.000476	0.000703	CcSEcCtD
Terazosin—Body temperature increased—Epirubicin—uterine cancer	0.000476	0.000703	CcSEcCtD
Terazosin—Abdominal pain—Epirubicin—uterine cancer	0.000476	0.000703	CcSEcCtD
Terazosin—Feeling abnormal—Doxorubicin—uterine cancer	0.000459	0.000678	CcSEcCtD
Terazosin—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000455	0.000672	CcSEcCtD
Terazosin—Hypersensitivity—Epirubicin—uterine cancer	0.000443	0.000655	CcSEcCtD
Terazosin—Abdominal pain—Doxorubicin—uterine cancer	0.00044	0.00065	CcSEcCtD
Terazosin—Body temperature increased—Doxorubicin—uterine cancer	0.00044	0.00065	CcSEcCtD
Terazosin—Asthenia—Epirubicin—uterine cancer	0.000432	0.000638	CcSEcCtD
Terazosin—Pruritus—Epirubicin—uterine cancer	0.000426	0.000629	CcSEcCtD
Terazosin—Diarrhoea—Epirubicin—uterine cancer	0.000412	0.000608	CcSEcCtD
Terazosin—Hypersensitivity—Doxorubicin—uterine cancer	0.00041	0.000606	CcSEcCtD
Terazosin—Asthenia—Doxorubicin—uterine cancer	0.0004	0.00059	CcSEcCtD
Terazosin—Dizziness—Epirubicin—uterine cancer	0.000398	0.000588	CcSEcCtD
Terazosin—Pruritus—Doxorubicin—uterine cancer	0.000394	0.000582	CcSEcCtD
Terazosin—Vomiting—Epirubicin—uterine cancer	0.000383	0.000565	CcSEcCtD
Terazosin—Diarrhoea—Doxorubicin—uterine cancer	0.000381	0.000563	CcSEcCtD
Terazosin—Rash—Epirubicin—uterine cancer	0.00038	0.00056	CcSEcCtD
Terazosin—Dermatitis—Epirubicin—uterine cancer	0.000379	0.00056	CcSEcCtD
Terazosin—Headache—Epirubicin—uterine cancer	0.000377	0.000557	CcSEcCtD
Terazosin—Dizziness—Doxorubicin—uterine cancer	0.000368	0.000544	CcSEcCtD
Terazosin—Nausea—Epirubicin—uterine cancer	0.000358	0.000528	CcSEcCtD
Terazosin—Vomiting—Doxorubicin—uterine cancer	0.000354	0.000523	CcSEcCtD
Terazosin—Rash—Doxorubicin—uterine cancer	0.000351	0.000518	CcSEcCtD
Terazosin—Dermatitis—Doxorubicin—uterine cancer	0.000351	0.000518	CcSEcCtD
Terazosin—Headache—Doxorubicin—uterine cancer	0.000349	0.000515	CcSEcCtD
Terazosin—Nausea—Doxorubicin—uterine cancer	0.000331	0.000488	CcSEcCtD
